Supreme Court asks DOJ to weigh in on Hikma ‘skinny label’ fight
The US Supreme Court on Monday invited the US solicitor general to comment on a generic drug label case that Hikma Pharmaceuticals says could “effectively vitiate” a common practice for bringing low-cost medications to market ...
The US Supreme Court on Monday invited the US solicitor general to comment on a generic drug label case that Hikma Pharmaceuticals says could “effectively vitiate” a common practice for bringing low-cost medications to market ...
